People with higher exposure to traffic-related air pollution were more likely to have high amounts of amyloid plaques in their brains associated with Alzheimer’s disease after death, according to a study published in the February 21, 2024, online issue of Neurology®, the medical journal of the American Academy of Neurology.
Stay informed! These are the latest research articles on "Long COVID" from the Coronavirus News Source on Newswise.
Researchers at West Virginia University have identified a set of diagnostic metabolic biomarkers that can help them develop artificial intelligence tools to detect Alzheimer’s disease in its early stages, as well as determine risk factors and treatment interventions.
A team led by scientists at the Case Western Reserve University School of Medicine has identified a new therapeutic approach for combating neurodegenerative diseases.
Rutgers study led by undergrads and gap-year students breaks ground in the field of neuroscience and suggests experimental medication could treat dementia.
Neuroscientists at Macquarie University in Australia have developed a single-dose genetic medicine that has been proven to halt the progression of both ALS and frontotemporal dementia (FTD) in mice – and may even offer the potential to reverse some of the effects of the fatal diseases.
Professor Eef Hogervorst, Professor of Biological Psychology at Loughborough University, sits down to discuss the factors influencing the menopause, what the best treatment options are, the relationship between oestrogen and dementia, and the controversies surrounding the andropause (the ‘male menopause’).
A new study has laid the groundwork for a future intervention designed to help caregivers establish a safe and workable mealtime routine for people with dementia living at home.
Irvine, Calif., Feb. 14, 2024 — A research team led by the University of California, Irvine has created 20 new recombinant rabies viral vectors for neural circuit mapping that offer a range of significant advantages over existing tools, including the ability to detect microstructural changes in models of aging and Alzheimer’s disease brain neurons.
Clinical studies suggest the Mediterranean diet, and one of its main components, extra virgin olive oil (EVOO), improves cognitive function and slows Alzheimer's disease (AD) progression. Researchers will now investigate whether this is true even for people with a family history of AD and signs of genetic predisposition caused by dysfunction in the APOE gene.
A team of scientists from Wake Forest University School of Medicine and the University of Southern California (USC) have demonstrated the first successful use of a neural prosthetic device to recall specific memories.
Below are some of the latest research and features on this growing population of older adults in the Seniors channel on Newswise.
Immigrants living with dementia were more likely to present with agitation and aggression compared with their non-immigrant counterparts, a new study by Edith Cowan University (ECU) in collaboration with The Dementia Centre, HammondCare, found.
Improving the way scientists can see the microscopic structures of the brain can improve our understanding of a host of brain diseases, like Alzheimer’s or multiple sclerosis. Studying these diseases is challenging and has been limited by accuracy of available models.To see the smallest parts of cells, scientists often use a technique called electron microscopy.
In an effort five years in the making, UNC School of Medicine cell biologist Sarah Cohen, PhD, and Rockefeller University’s Ian Windham, PhD, describe the interplay between fats and proteins in brain cells and how their dysfunction contributes to the development of late-onset Alzheimer’s disease.
University Hospitals Brain Health & Memory Center is now treating patients with LEQEMBI® (lecanemab), a Food and Drug Administration-approved medication for the treatment of Alzheimer’s disease.
Rutgers Health researchers find differences among Asian older adults’ support of research and inclination to receive MRI results.
The drugs used to treat erectile dysfunction may also be associated with a reduced risk of Alzheimer’s disease, according to a study published in the February 7, 2024, online issue of Neurology®, the medical journal of the American Academy of Neurology.
Designing sensitive and single-use biosensors for early diagnosis remains a major challenge. Scientists in China invented submonolayer lasers on optical fibers as ultrasensitive and disposable biosensors.
A potential new drug to prevent Alzheimer’s disease in people with the so-called Alzheimer’s gene has been discovered by a University of Arkansas for Medical Sciences (UAMS) research team led by Sue Griffin, Ph.D.
Two Rutgers professors, both leading Alzheimer's disease researchers, have partnered with Tel Aviv University and Hebrew University to organize the US-Israel Alzheimer’s Disease Conference in Tel Aviv.
Researchers have discovered why a gene that, when mutated, is a common cause of two debilitating brain diseases.
Since its introduction to the public in November 2022, ChatGPT, an artificial intelligence system, has substantially grown in use, creating written stories, graphics, art and more with just a short prompt from the user.
Nicolas Musi, MD, studies a spectrum of age-related disorders that can impact a healthy lifespan.
A team of University of Wisconsin–Madison scientists has developed the first 3D-printed brain tissue that can grow and function like typical brain tissue.
Hydrogen peroxide is crucial in cell metabolism, playing key roles in cell proliferation, differentiation, and migration. However, elevated levels of hydrogen peroxide (H2O2) are linked to several diseases, including cancer and neurodegenerative disorders like Alzheimer's and Parkinson's disease.
Left unchecked, hearing loss can lead to lead to social isolation and depression – two conditions proven to hasten dementia. A Penn State Health expert sounds off on what you can do about it.
University at Albany scientist Scott Tenenbaum, founder of UAlbany spinoff company sxRNA Technologies, Inc. (sxRNA Tech), has received $500,000 from the National Institute on Aging, part of the National Institutes of Health, to study how aging brain cells shape the progression of Alzheimer’s disease, and advance RNA technology that could inform new therapeutics to prevent and treat Alzheimer's and related dementias.
A new therapeutic for stroke based on University of Georgia research will soon enter clinical trials.
RUDN University chemists have obtained new azaheterocyclic compounds that inhibit acetylcholinesterase (AChE) and butyrylcholinesterase (BChE), regulators of the central nervous system.
The latest research and expertise on the flue can be found in the Influenza channel on Newswise.
Compared to urban dwellers, racially/ethnically diverse older adults face up to an 80 percent greater risk of cognitive impairment in older age, and 2.5 times potentially preventable Alzheimer’s-related (ADRD) hospitalizations.
Protein degraders offer a novel approach to targeting undruggable diseases by hijacking the cell's degradation machinery.
Nerve cells in the brain demand an enormous amount of energy to survive and maintain their connections for communicating with other nerve cells.
A new study from UC Davis Health and Oregon Health & Science University reveals significant disparities in dementia care.
Quiet Events®, a leader in Silent Disco events and rentals, announces an exciting new partnership with the Day By Day Project, a pioneer in the innovative Memory Disco™ program.
A Beckman study led by Paul Bogdan and Florin and Sanda Dolcos suggests the moments that follow a distressing episode are more memorable than the moments leading up to it.
This research from UNC-Chapel Hill, published in the journal Nature Communications, opens the door to researching this wirelessly controlled patch to deliver on-demand treatments for neurodegenerative disorders, including Alzheimer’s disease.
UC Davis Health and Kaiser Permanente Division of Research received a $24 million grant from the National Institute on Aging, part of the NIH, to continue the Study of Healthy Aging in African Americans (STAR).
Approximately 23% of people diagnosed with Alzheimer’s disease or another related dementia in their 60s and later have cases that can be explained by controllable risk factors such as high blood pressure, diabetes, physical inactivity, and too little or too much sleep, and that percentage varies depending on race and ethnicity, according to a new study published in the January 17, 2024, online issue of Neurology®, the medical journal of the American Academy of Neurology.
Is it possible to amp up the energy production of mitochondria, the “power centers” of cells, without also boosting potentially harmful byproducts? If so, such a method could be used to treat a host of neurodegenerative diseases in which impaired mitochondria are believed to play a central role.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right
